Retrospective analysis of ustekinumab in Crohn's disease between biologic-naïve and biologic-experienced. (PubMed, Front Gastroenterol (Lausanne)) - Oct 8, 2026 - "The quality of life of patients who achieved a clinical response has improved more significantly. Anxiety symptoms can be somewhat alleviated, while the depressive state has not shown any significant change."
Journal • Retrospective data • CNS Disorders • Crohn's disease • Depression • Gastroenterology • Immunology • Inflammation • Inflammatory Bowel Disease • Mood Disorders • Psychiatry
|
|
Baijing Ding; Kaifei Yuan; Ping Lin; Qi Fang; Siyuan Li; Tongyuan Lin; Xianhong Hu
|